Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost €15.00 Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost quantity Add to cart Category: Articles Tag: Volume 3 Description Description Authors: Janet B. Serle, Jake Radell Related products The 810 Nm I.R. Diode Laser in the pivotal paradigm shift from laser photocoagulation to laser photostimulation €15.00 Add to cart Structure-function relationships in the optic nerve head and the consequences of regional pressure disturbances €15.00 Add to cart IOP homeostasis ? Why most people do not ever develop glaucoma €15.00 Add to cart Dynamic mechanobiology of conventional outflow €15.00 Add to cart